Literature DB >> 9454736

Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis.

J C Mills1, V M Lee, R N Pittman.   

Abstract

The execution phase is an evolutionarily conserved stage of apoptosis that occurs with remarkable temporal and morphological uniformity in most if not all cell types regardless of the condition used to induce death. Characteristic features of apoptosis such as membrane blebbing, DNA fragmentation, chromatin condensation, and cell shrinkage occur during the execution phase; therefore, there is considerable interest in defining biochemical changes and signaling events early in the execution phase. Since onset of the execution phase is asynchronous across a population with only a small fraction of cells in this stage at any given time, characterizing underlying biochemical changes is difficult. An additional complication is recent evidence suggesting that the execution phase occurs after cells commit to die; thus, agents that modulate events in the execution phase may alter the morphological progression of apoptosis but will not affect the time-course of death. In the present study, we use a single cell approach to study and temporally order biochemical and cytoskeletal events that occur specifically in the execution phase. Microtubules de-acetylate and disassemble as terminally differentiated PC12 cells enter the execution phase following removal of nerve growth factor. Using phosphorylation sensitive antibodies to tau, we show that this microtubule-stabilizing protein becomes dephosphorylated near the onset of the execution phase. Low concentrations of okadaic acid inhibit dephosphorylation suggesting a PP2A-like phosphatase is responsible. Transfecting (tau) into CHO cells to act as a 'reporter' protein shows a similar dephosphorylation of (tau) by a PP2A-like phosphatase during the execution phase following induction of apoptosis with UV irradiation. Therefore, activation of PP2A phosphatase occurs at the onset of the execution phase in two very different cell types following different initiators of apoptosis which is consistent with activation of PP2A phosphatase being a common feature of the execution phase of apoptosis. Experiments using either taxol to inhibit microtubule disassembly or okadaic acid to inhibit tau dephosphorylation suggest that microtubule disassembly is necessary for tau dephosphorylation to occur. Thus, we propose that an early step in the execution phase (soon after a cell commits to die) is microtubule disassembly which frees or activates PP2A to dephosphorylate tau as well as other substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454736     DOI: 10.1242/jcs.111.5.625

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  17 in total

1.  Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits.

Authors:  Adam M Silverstein; Christina A Barrow; Anthony J Davis; Marc C Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Cooperative control of Akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells.

Authors:  D A Flusberg; Y Numaguchi; D E Ingber
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

Review 3.  Disassembly of dying cells in diverse organisms.

Authors:  Rochelle Tixeira; Ivan K H Poon
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

4.  PP2A contributes to endothelial death in high glucose: inhibition by benfotiamine.

Authors:  Y Du; A Kowluru; T S Kern
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

5.  Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity.

Authors:  K A McMahon; N J Wilson; D C Marks; T L Beecroft; G A Whitty; J A Hamilton; X F Csar
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

6.  Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression.

Authors:  Wei Chen; Xiao-Bing Fu; Shi-Li Ge; Tong-Zhu Sun; Gang Zhou; Bing Han; Yi-Ri Du; Hai-Hong Li; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

7.  Dual regulation of diacylglycerol kinase (DGK)-θ: polybasic proteins promote activation by phospholipids and increase substrate affinity.

Authors:  Becky Tu-Sekine; Daniel M Raben
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

8.  Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid.

Authors:  Rafat A Siddiqui; Laura J Jenski; Kevin A Harvey; Jacqueline D Wiesehan; William Stillwell; Gary P Zaloga
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

Review 9.  Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.

Authors:  Tomás A Santa-Coloma
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 10.  In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease.

Authors:  Nadia Canu; Pietro Calissano
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.